161 related articles for article (PubMed ID: 7361860)
1. Light-microscopic analysis of sectioned Sézary cells: an accurate alternative to electron microscopy.
Myrie C; Zucker-Franklin D; Ramsey D
Am J Pathol; 1980 Apr; 99(1):243-52. PubMed ID: 7361860
[TBL] [Abstract][Full Text] [Related]
2. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy.
Schechter GP; Bunn PA; Fischmann AB; Matthews MJ; Guccion J; Soehnlen F; Munson D; Minna JD
Cancer Treat Rep; 1979 Apr; 63(4):571-4. PubMed ID: 312694
[TBL] [Abstract][Full Text] [Related]
3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
4. Circulating Sézary cells. A new preparatory method for their identification and enumeration.
Fletcher V; Zackheim HS; Beckstead JH
Arch Pathol Lab Med; 1984 Dec; 108(12):954-8. PubMed ID: 6239604
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
Kim YH; Bishop K; Varghese A; Hoppe RT
Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
[TBL] [Abstract][Full Text] [Related]
6. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
Matejka M; Konrad K
Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
8. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural appearance of cutaneous T cell lymphomas in skin, lymph nodes, and peripheral blood.
Guccion JG; Fischmann AB; Bunn PA; Schechter GP; Patterson RH; Matthews MJ
Cancer Treat Rep; 1979 Apr; 63(4):565-70. PubMed ID: 312693
[No Abstract] [Full Text] [Related]
10. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
[TBL] [Abstract][Full Text] [Related]
11. Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report.
Agar N; Whittaker SJ
Br J Dermatol; 2008 Nov; 159(5):1197-9. PubMed ID: 18764843
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.
Gahongayire F
Int J Dermatol; 2007 Oct; 46 Suppl 1():32-5. PubMed ID: 17919204
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
[TBL] [Abstract][Full Text] [Related]
14. Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation.
McCusker ME; Garifallou M; Bogen SA
J Immunol; 1997 May; 158(10):4984-91. PubMed ID: 9144518
[TBL] [Abstract][Full Text] [Related]
15. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
[TBL] [Abstract][Full Text] [Related]
16. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
17. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
Wechsler J; Diebold J; Gerard-Marchant R
Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
[TBL] [Abstract][Full Text] [Related]
18. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
Tan ES; Tang MB; Tan SH
Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of T-plastin in Sezary cells.
Su MW; Dorocicz I; Dragowska WH; Ho V; Li G; Voss N; Gascoyne R; Zhou Y
Cancer Res; 2003 Nov; 63(21):7122-7. PubMed ID: 14612505
[TBL] [Abstract][Full Text] [Related]
20. Sézary cells in ascitic fluid.
Vernon SE; Rosenthal DL
Acta Cytol; 1979; 23(5):408-11. PubMed ID: 316632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]